...
首页> 外文期刊>Nanoscale Research Letters >Novel Chemo-Photothermal Therapy in Breast Cancer Using Methotrexate-Loaded Folic Acid Conjugated Au@SiO 2 Nanoparticles
【24h】

Novel Chemo-Photothermal Therapy in Breast Cancer Using Methotrexate-Loaded Folic Acid Conjugated Au@SiO 2 Nanoparticles

机译:使用甲氨蝶呤加载叶酸共轭Au @ siO 2 纳米粒子的新型化疗 - 光热疗法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Low level laser therapy (LLLT) is known as a safe type of phototherapy to target tumor tissue/cells. Besides, using targeted nanoparticles increases the successfulness of cancer therapy. This study was designed for investigating the combined effect of folate (FA)/Methotrexate (MTX) loaded silica coated gold (Au@SiO_(2)) nanoparticles (NPs) and LLLT on the fight against breast cancer. NPs were synthesized and characterized using FTIR, TEM and DLS-Zeta. The NPs had spherical morphology with mean diameter of around 25 nm and positive charge (+13.3 mV) while after conjugation with FA and MTX their net charge reduced to around -19.7 mV. Our findings in cell uptake studies clearly showed enhanced cellular uptake of NPs after FA and MTX loaded NPs in both breast cancer cell lines especially on MDA-MB-231 due to high expression of folate receptors. The results indicated that LLLT had a proliferative effect on both breast cancer cell lines but in the presence of engineered breast cancer targeted nanoparticle, the efficacy of combination chemo-photothermal therapy was significantly increased using MTT assay (p<0.05), DAPI staining, and cell cycle findings. The highest apoptotic effect on breast cancer cell lines was observed in the cells exposed to a combination of MTX-FA loaded Au@SiO_(2)NP and LLLT proved by DAPI staining and cell cycle(by increasing the cell arrest in subG0/G1). Taken together a combination of chemotherapy and LLLT improves the potential of breast cancer therapy with minimum side effects.
机译:低水平激光治疗(LLLT)被称为靶向肿瘤组织/细胞的安全类型的光疗法。此外,使用靶向纳米颗粒增加了癌症治疗的成功。本研究旨在研究叶酸(FA)/甲氨蝶呤(MTX)载有二氧化硅涂覆的金(Au @ SiO_(2))纳米颗粒(NPS)和LLLT对抗乳腺癌的综合作用。使用FTIR,TEM和DLS-Zeta合成并表征NPS。 NPS具有平均直径约为25nm和正电荷(+13.3mV)的球形形态,同时与FA和MTX缀合后,它们的净电荷降低至约-19.7mV。我们在细胞摄取研究中的发现清楚地显示出在FA和MTX中的NPS在乳腺癌细胞系中加载NPS的增强的细胞摄取,特别是由于叶酸受体高表达,乳腺癌细胞系中的MDA-MB-231。结果表明,LLLT对乳腺癌细胞系具有增殖作用,但在工程化的乳腺癌靶向纳米粒子存在下,使用MTT测定(P <0.05),DAPI染色和组合的化学光热疗的疗效显着增加。细胞周期调查结果。在暴露于DAPI染色和细胞周期的MTX-FA负载的Au @ SiO_(2)NP和Lllt的组合的细胞中观察到乳腺癌细胞系对乳腺癌细胞系的最高凋亡效应(通过增加Subg0 / g1中的细胞停滞) 。一起组合化疗和LLLT提高了乳腺癌治疗的潜力,最小副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号